MassLive (Jochem, G.) 10.06.2023, published “Western Massachusetts woman files lawsuit over home test for Lyme disease.” A lawsuit has been filed in Springfield’s U.S. District Court against LetsGetChecked, a company providing a home test for Lyme disease. Moira Kerans from Dalton and TruthCures, a nonprofit focused on Lyme disease, are the plaintiffs seeking $5 million in damages. They allege that the test is inaccurate, deceives customers, and violates consumer protection laws.
Industry Dive (Alvarado, D.) 12.05.2023, published “Pfizer, after delay, completes enrollment in Lyme vaccine trial.” Pfizer and Valneva completed enrollment for a Phase 3 trial of their Lyme disease vaccine, ending a delay sparked by concerns about trial misconduct. The FDA found no wrongdoing, but the study’s completion is pushed back to 2025.
The Pittsburgh Post-Gazette (Hayes, J.) 12.03.2023, published “Reproductive anomaly enables a tick species to race into Pennsylvania.” The Asian longhorned tick, a parasite from Southeast Asia, is posing a significant threat to livestock, wildlife, and pets across 19 states, including Pennsylvania. This invasive species, known for reproducing asexually, has rapidly spread since its arrival in the United States in 2017 and has been confirmed in numerous Pennsylvania counties and city parks.
Forbes (Bauhaus, J.M.) 12.01.2023, published “Doxycycline For Dogs: Safe Dosages And Uses.” This article covers the use of doxycycline in treating various infections and conditions in dogs, including Lyme disease, heartworms, respiratory infections, dental issues, and more. Doxycycline, an antibiotic with broad-spectrum properties, inhibits bacterial growth and is often prescribed by veterinarians. It’s available in different forms, like tablets, liquids, and gels.
The Journal of Clinical Investigation (Li, D., et al.) 11.14.2023, published “Spliceosome malfunction causes neurodevelopmental disorders with overlapping features.” The article discusses neurodevelopmental disorders arise during childhood (NDDs), a diverse group including autism spectrum disorder and intellectual disability.
eBioMedicine (Vrijmoeth, H.D., et al.) 11.27.2023 published “Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.” In this study, researchers assessed 1135 physician-confirmed Lyme disease patients from the time of initiation of treatment with antibiotics to a one year follow-up. Findings showed that the determinants of persistent symptoms after Lyme disease infections and initial treatment were considered “mainly generic.” Determinants of 295 patients with persistent symptoms included a baseline of physical and social functioning that was poorer, depression and anxiety scores that were higher, illness perceptions that were more negative, as well as having baseline comorbidities, fatigue, cognitive impairment, and pain.
The People’s Pharmacy, Joe Graedon, (11.28.2023) reports “New Concerns About Gabapentin and Pregabalin (Lyrica) for Nerve Pain.” Concerning data has come out of the FDA’s Adverse Event Reporting System (FAERS) regarding drugs that are regularly prescribed for nerve pain.
Frontiers (Alruwaili, Y., et al.) 11.21.2023, published “Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease.” This article delves into Lyme disease caused by Borrelia burgdorferi, a prevalent tick-borne infection in North America. While most cases are treatable with antibiotics, a subset of patients experiences chronic symptoms known as […]
The Journal of Pediatric Ophthalmology & Strabismus (Silverstein M., et al.) 10.25.2023, published “Yearly Occurrence and Seasonality of Neuro-ophthalmic Manifestations of Pediatric Lyme Disease.” This article reviews the manifestation of visual problems related to the nervous system in relation to Lyme disease in at a central Ohio pediatric tertiary care center.
5 On Your Side (Bassler, H.) 11.22.2023, published “A sesame seed-sized tick is spreading across Missouri. Here’s what to know.” The article discusses the spread of various tick-borne diseases in Missouri, particularly due to the invasive Asian longhorned tick. This tick was first reported in the U.S. in 2017, but potentially present since before 2010. It has been detected across multiple states and is known for transmitting diseases like anaplasmosis, babesiosis, ehrlichiosis, […]